AS attenuates memory impairment induced by transient cerebral ischemia–reperfusion.
AS exhibits anti-inflammation activity in cerebral ischemia–reperfusion in mice.
The effects of AS may be related to anti-inflammation and inhibition of microglia.
AS may play its anti-inflammation activity via suppression of p38 MAPK pathway.
AS may be a candidate therapy for ischemic brain injury.